Literature DB >> 28578924

Letter to the Editor: Influence of rTMS on smoking in patients with schizophrenia.

Daniel Kamp1, Christina Engelke2, Thomas Wobrock3, Birgit Kunze4, Wolfgang Wölwer5, Georg Winterer6, Christian Schmidt-Kraepelin7, Wolfgang Gaebel8, Berthold Langguth9, Michael Landgrebe10, Peter Eichhammer11, Elmar Frank12, Göran Hajak13, Christian Ohmann14, Pablo E Verde15, Marcella Rietschel16, Ahmed Raees17, William G Honer18, Berend Malchow19, Thomas Schneider-Axmann20, Peter Falkai21, Alkomiet Hasan22, Joachim Cordes23.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28578924     DOI: 10.1016/j.schres.2017.05.036

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  6 in total

1.  Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead.

Authors:  Hamed Ekhtiari; Hosna Tavakoli; Giovanni Addolorato; Chris Baeken; Antonello Bonci; Salvatore Campanella; Luis Castelo-Branco; Gaëlle Challet-Bouju; Vincent P Clark; Eric Claus; Pinhas N Dannon; Alessandra Del Felice; Tess den Uyl; Marco Diana; Massimo di Giannantonio; John R Fedota; Paul Fitzgerald; Luigi Gallimberti; Marie Grall-Bronnec; Sarah C Herremans; Martin J Herrmann; Asif Jamil; Eman Khedr; Christos Kouimtsidis; Karolina Kozak; Evgeny Krupitsky; Claus Lamm; William V Lechner; Graziella Madeo; Nastaran Malmir; Giovanni Martinotti; William M McDonald; Chiara Montemitro; Ester M Nakamura-Palacios; Mohammad Nasehi; Xavier Noël; Masoud Nosratabadi; Martin Paulus; Mauro Pettorruso; Basant Pradhan; Samir K Praharaj; Haley Rafferty; Gregory Sahlem; Betty Jo Salmeron; Anne Sauvaget; Renée S Schluter; Carmen Sergiou; Alireza Shahbabaie; Christine Sheffer; Primavera A Spagnolo; Vaughn R Steele; Ti-Fei Yuan; Josanne D M van Dongen; Vincent Van Waes; Ganesan Venkatasubramanian; Antonio Verdejo-García; Ilse Verveer; Justine W Welsh; Michael J Wesley; Katie Witkiewitz; Fatemeh Yavari; Mohammad-Reza Zarrindast; Laurie Zawertailo; Xiaochu Zhang; Yoon-Hee Cha; Tony P George; Flavio Frohlich; Anna E Goudriaan; Shirley Fecteau; Stacey B Daughters; Elliot A Stein; Felipe Fregni; Michael A Nitsche; Abraham Zangen; Marom Bikson; Colleen A Hanlon
Journal:  Neurosci Biobehav Rev       Date:  2019-07-02       Impact factor: 8.989

2.  Effects of short-term, high-frequency repetitive transcranial magnetic stimulation to bilateral dorsolateral prefrontal cortex on smoking behavior and cognition in patients with schizophrenia and non-psychiatric controls.

Authors:  Karolina Kozak; Maryam Sharif-Razi; Marya Morozova; Erin V Gaudette; Mera S Barr; Zafiris J Daskalakis; Daniel M Blumberger; Tony P George
Journal:  Schizophr Res       Date:  2018-02-24       Impact factor: 4.939

3.  Two weeks of image-guided left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation improves smoking cessation: A double-blind, sham-controlled, randomized clinical trial.

Authors:  Xingbao Li; Karen J Hartwell; Scott Henderson; Bashar W Badran; Kathleen T Brady; Mark S George
Journal:  Brain Stimul       Date:  2020-06-10       Impact factor: 8.955

4.  The two-way relationship between nicotine and cortical activity: a systematic review of neurobiological and treatment aspects.

Authors:  Carlota de Miquel; Benjamin Pross; Irina Papazova; Duygu Güler; Alkomiet Hasan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-27       Impact factor: 5.270

5.  Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review.

Authors:  Samantha Johnstone; Maryam Sorkhou; Nada Al-Saghir; Darby J E Lowe; Vaughn R Steele; Godfrey D Pearlson; David J Castle; Tony P George
Journal:  Front Psychiatry       Date:  2022-02-14       Impact factor: 4.157

Review 6.  Noninvasive Brain Stimulation for Nicotine Dependence in Schizophrenia: A Mini Review.

Authors:  Heather Burrell Ward; Roscoe O Brady; Mark A Halko; Paulo Lizano
Journal:  Front Psychiatry       Date:  2022-02-09       Impact factor: 5.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.